Aimei Health Technology Co., Ltd. 8-K

What Happened
Aimei Health Technology Co., Ltd. (AFJK) announced on an 8‑K that on April 17, 2026 it received a notice from Nasdaq’s Listing Qualifications staff saying the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 10‑K for the year ended December 31, 2025. The 10‑K was due March 31, 2026; the company filed a Form 12b‑25 (Notification of Late Filing) with the SEC on April 1, 2026 and issued a press release on April 21, 2026.

Key Details

• Nasdaq notice date: April 17, 2026; 10‑K due date: March 31, 2026.
• Company previously filed Form 12b‑25 on April 1, 2026 to notify of the late 10‑K.
• Nasdaq gives 60 calendar days from the notice to either file the 10‑K or submit a compliance plan; if a plan is accepted, up to 180 days from the original due date may be allowed.
• The notice has no immediate effect on trading, but failure to regain compliance could lead to delisting.

Why It Matters
This is a compliance and disclosure risk item that investors should monitor. Timely SEC filings (like Form 10‑K) are required for transparency into a company’s financial condition; missing them can trigger Nasdaq delisting proceedings if not resolved. Aimei says it is working to complete and file the Annual Report and expects to regain compliance, but provides no guaranteed timing.